New insights into Hippo/YAP signaling in fibrotic diseases

MM Mia, MK Singh - Cells, 2022 - mdpi.com
Fibrosis results from defective wound healing processes often seen after chronic injury
and/or inflammation in a range of organs. Progressive fibrotic events may lead to permanent …

YAP/TAZ: Molecular pathway and disease therapy

Y Wei, VLZ Hui, Y Chen, R Han, X Han, Y Guo - MedComm, 2023 - Wiley Online Library
The Yes‐associated protein and its transcriptional coactivator with PDZ‐binding motif
(YAP/TAZ) are two homologous transcriptional coactivators that lie at the center of a key …

mTOR signaling network in cell biology and human disease

JJ Yu, EA Goncharova - International journal of molecular sciences, 2022 - mdpi.com
The mechanistic target of rapamycin (mTOR) is a serine/threonine protein kinase that
regulates multiple processes, including gene transcription, protein synthesis, ribosome …

Nucleosome assembly protein 1 like 1 (NAP1L1) promotes cardiac fibrosis by inhibiting YAP1 ubiquitination and degradation

T Li, Z Niu, T Yu, J Li, X Lu, M Huang, Q Wang… - MedComm, 2023 - Wiley Online Library
Myocardial fibrosis post myocardial infarction (MI) is characterized by abnormal extracellular
matrix (ECM) deposition and cardiac dysfunction could finally develop into serious heart …

The Hippo-YAP pathway in various cardiovascular diseases: focusing on the inflammatory response

A Zheng, Q Chen, L Zhang - Frontiers in immunology, 2022 - frontiersin.org
The Hippo pathway was initially discovered in Drosophila melanogaster and mammals as a
key regulator of tissue growth both in physiological and pathological states. Numerous …

A review on decoding the roles of YAP/TAZ signaling pathway in cardiovascular diseases: Bridging molecular mechanisms to therapeutic insights

Y Zhang, Y Ren, X Li, M Li, M Fu, W Zhou, Y Yu… - International Journal of …, 2024 - Elsevier
Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ)
serve as transcriptional co-activators that dynamically shuttle between the cytoplasm and …

Hippo signaling impairs alveolar epithelial regeneration in pulmonary fibrosis

R Warren, H Lyu, K Klinkhammer, SP De Langhe - Elife, 2023 - elifesciences.org
Idiopathic pulmonary fibrosis (IPF) consists of fibrotic alveolar remodeling and progressive
loss of pulmonary function. Genetic and experimental evidence indicates that chronic …

An updated review of YAP: A promising therapeutic target against cardiac aging?

J Leng, C Wang, Z Liang, F Qiu, S Zhang… - International Journal of …, 2024 - Elsevier
The transcriptional co-activator Yes-associated protein (YAP) functions as a downstream
effector of the Hippo signaling pathway and plays a crucial role in cardiomyocyte survival. In …

The Multifaceted Roles of Hippo-YAP in Cardiovascular Diseases

H Wu, YN Che, Q Lan, YX He, P Liu, MT Chen… - Cardiovascular …, 2024 - Springer
The Hippo-yes-associated protein (YAP) signaling pathway plays a crucial role in cell
proliferation, differentiation, and death. It is known to have impact on the progression and …

Connexin 43 dephosphorylation mediates the Dchs1/YAP/TEAD signaling pathway to induce cardiac fibrosis

M Wang, W Li, Y Shao, F Wang, Y Huang, C Wei… - … et Biophysica Acta (BBA …, 2025 - Elsevier
Background The gap junction protein connexin 43 (Cx43) has been implicated in the
development of cardiac fibrosis. Our previous findings revealed that Cx43 …